Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Goodwill (2016 - 2025)

Historic Goodwill for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $581.2 million.

  • Prestige Consumer Healthcare's Goodwill rose 1024.79% to $581.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $581.2 million, marking a year-over-year increase of 1024.79%. This contributed to the annual value of $527.4 million for FY2025, which is 5.84% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Goodwill stood at $581.2 million for Q4 2025, which was up 1024.79% from $528.4 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Goodwill's 5-year high stood at $581.2 million during Q4 2025, with a 5-year trough of $526.9 million in Q3 2023.
  • Moreover, its 5-year median value for Goodwill was $528.8 million (2024), whereas its average is $550.5 million.
  • In the last 5 years, Prestige Consumer Healthcare's Goodwill tumbled by 888.17% in 2023 and then surged by 1024.79% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Goodwill stood at $578.9 million in 2021, then fell by 0.4% to $576.6 million in 2022, then decreased by 8.45% to $527.9 million in 2023, then fell by 0.12% to $527.2 million in 2024, then increased by 10.25% to $581.2 million in 2025.
  • Its last three reported values are $581.2 million in Q4 2025, $528.4 million for Q3 2025, and $528.3 million during Q2 2025.